The synthesis of a range of phosphinite ligands PR2(OAr) (R = Ph, iPr), their simple complexes with palladium(II) and their palladacyclic complexes has been investigated. The crystal structure of one of the palladacyclic complexes, [{Pd(μ2-Cl){κ2-P,C-PiPr2(OC6H2-2,4-tBu2)}2], has been determined. The palladacyclic complexes show extremely high activity in the Suzuki coupling of aryl bromide substrates with phenylboronic acid and can also be used with alkylboronic acid substrates. A comparison of the phosphinite-based catalysts with equivalent phosphite- and phosphine-based systems highlights their superior activity. The orthometallation of the phosphinite ligand in the pre-catalyst appears to be crucial for optimal activity. While the phosphinite palladacycles are only moderately active in the coupling of activated and non-activated aryl chloride substrates, their tricyclohexylphosphine adducts prove to be highly active in the coupling of the deactivated substrate, 4-chloroanisole. This high activity compared with other palladacyclic systems is explained in terms of catalyst longevity. The orthometallated precatalysts appear to undergo a reductive activation process to generate zerovalent active catalysts via reductive elimination of the orthometallated ring with a phenyl introduced by the boronic acid. This implies that the true active catalysts contain 2-arylated ligands. Catalysts formed with such 2-arylated ligands tend to show markedly higher activity than their parent ligands.
No takes yet. Share an insight, caveat, or question.
Bedford et al. (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: